Boris Brumshtein

1.6k citations

18 papers · 1.3k indexed · 1 hit paper · h-index 15

Co-authors: Joel L. Sussman Israel Silman Michal Harel Lilly Toker Anthony H. Futerman Hay Dvir Andrew A. McCarthy Ran Meged
Topics: Glycosylation and Glycoproteins Research (7 papers)Carbohydrate Chemistry and Synthesis (6 papers)Lysosomal Storage Disorders Research (5 papers)
Cited by: Clinical Biochemistry Biochemistry Pharmacology
Journals: Journal of Biological Chemistry Journal of Medicinal Chemistry Nature Structural & Molecular Biology
Partner nations: Israel United States France

In The Last Decade

Boris Brumshtein

18 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes

2004 501 citations Michal Harel, Amir Aharoni et al. Nature Structural & Molecular Biology profile →

Peers

Countries citing papers authored by Boris Brumshtein

Since Specialization

Citations

This map shows the geographic impact of Boris Brumshtein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Brumshtein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Brumshtein more than expected).

Fields of papers citing papers by Boris Brumshtein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris Brumshtein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Brumshtein. The network helps show where Boris Brumshtein may publish in the future.

Co-authorship network of co-authors of Boris Brumshtein

This figure shows the co-authorship network connecting the top 25 collaborators of Boris Brumshtein. A scholar is included among the top collaborators of Boris Brumshtein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris Brumshtein. Boris Brumshtein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Design and Synthesis of Novel HIV-1 NNRTIs with Bicyclic Cores and with Improved Physicochemical Properties 2023 ·Journal of Medicinal Chemistry ·(unknown),Ondřej Baszczyňski,Martin Kaiser,Martin Dračínský,George Stepan,Yu‐Jen Lee,Boris Brumshtein,Helen Yu,Petr Jansa,E.B. Lansdon,Zlatko Janeba	11
2	Identification of two principal amyloid-driving segments in variable domains of Ig light chains in systemic light-chain amyloidosis 2018 ·Journal of Biological Chemistry ·Boris Brumshtein,Shannon R. Esswein,M.R. Sawaya,Gregory M. Rosenberg,(unknown),Meytal Landau,David Eisenberg	27
3	Inhibition by small-molecule ligands of formation of amyloid fibrils of an immunoglobulin light chain variable domain 2015 ·eLife ·Boris Brumshtein,Shannon R. Esswein,Łukasz Salwiński,Martin L. Phillips,(unknown),Duilio Cascio,M.R. Sawaya,David Eisenberg	49
4	Formation of Amyloid Fibers by Monomeric Light Chain Variable Domains 2014 ·Journal of Biological Chemistry ·Boris Brumshtein,Shannon R. Esswein,Meytal Landau,Christopher M. Ryan,Julian P. Whitelegge,Martin L. Phillips,Duilio Cascio,M.R. Sawaya,David Eisenberg	43
5	Cyclodextrin-mediated crystallization of acid β-glucosidase in complex with amphiphilic bicyclic nojirimycin analogues 2011 ·Organic & Biomolecular Chemistry ·Boris Brumshtein,Matilde Aguilar‐Moncayo,Juan M. Benito,José M. Garcı́a Fernández,Israel Silman,Yoseph Shaaltiel,David Aviezer,Joel L. Sussman,Anthony H. Futerman,Carmen Ortiz Mellet	30
6	6‐Amino‐6‐deoxy‐5,6‐di‐N‐(N′‐octyliminomethylidene)nojirimycin: Synthesis, Biological Evaluation, and Crystal Structure in Complex with Acid β‐Glucosidase 2009 ·ChemBioChem ·Boris Brumshtein,Matilde Aguilar‐Moncayo,M. Isabel García‐Moreno,Carmen Ortiz Mellet,José M. Garcı́a Fernández,Israel Silman,Yoseph Shaaltiel,David Aviezer,Joel L. Sussman,Anthony H. Futerman	45
7	Characterization of gene-activated human acid- -glucosidase: Crystal structure, glycan composition, and internalization into macrophages 2009 ·Glycobiology ·Boris Brumshtein,Patricia C. Salinas,B. A. Peterson,Virginia Chan,Israel Silman,Joel L. Sussman,(unknown),G.S. Robinson,Anthony H. Futerman	84
8	Control of the rate of evaporation in protein crystallization by the `microbatch under oil' method 2008 ·Journal of Applied Crystallography ·Boris Brumshtein,Harry M. Greenblatt,Anthony H. Futerman,Israel Silman,Joel L. Sussman	16
9	Acid β-glucosidase: insights from structural analysis and relevance to Gaucher disease therapy 2008 ·Biological Chemistry ·(unknown),Boris Brumshtein,Swetlana Boldin‐Adamsky,Lilly Toker,Alla Shainskaya,Israel Silman,Joel L. Sussman,Anthony H. Futerman	37
10	Crystal Structures of Complexes of N-Butyl- and N-Nonyl-Deoxynojirimycin Bound to Acid β-Glucosidase 2007 ·Journal of Biological Chemistry ·Boris Brumshtein,Harry M. Greenblatt,Terry D. Butters,Yoseph Shaaltiel,David Aviezer,Israel Silman,Anthony H. Futerman,Joel L. Sussman	100
11	3-D Structure of Serum Paraoxonase 1 Sheds Light on Its Activity, Stability, Solubility and Crystallizability 2007 ·Archives of Industrial Hygiene and Toxicology ·Michal Harel,Boris Brumshtein,Ran Meged,Hay Dvir,Raimond B. G. Ravelli,Andrew A. McCarthy,Lilly Toker,Israel Silman,Joel L. Sussman	27
12	Structural comparison of differently glycosylated forms of acid-β-glucosidase, the defective enzyme in Gaucher disease 2006 ·Acta Crystallographica Section D Biological Crystallography ·Boris Brumshtein,Mark R. Wormald,Israel Silman,Anthony H. Futerman,Joel L. Sussman	37
13	Complexes of Alkylene-Linked Tacrine Dimers with Torpedo californica Acetylcholinesterase: Binding of Bis(5)-tacrine Produces a Dramatic Rearrangement in the Active-Site Gorge 2006 ·Journal of Medicinal Chemistry ·Edwin H. Rydberg,Boris Brumshtein,Harry M. Greenblatt,Dawn M. Wong,David Shaya,Lawrence E. Williams,Paul R. Carlier,Yuan‐Ping Pang,Israel Silman,Joel L. Sussman	172
14	The Crystal Structure of the Complex of the Anticancer Prodrug 7-Ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothecin (CPT-11) with Torpedo californica Acetylcholinesterase Provides a Molecular Explanation for Its Cholinergic Action 2005 ·Molecular Pharmacology ·Michal Harel,Janice L. Hyatt,Boris Brumshtein,Christopher L. Morton,Kyoung Jin P. Yoon,Randy M. Wadkins,Israel Silman,Joel L. Sussman,Philip M. Potter	34
15	Inhibition of acetylcholinesterase by the anticancer prodrug CPT-11 2005 ·Chemico-Biological Interactions ·Janice L. Hyatt,Lyudmila Tsurkan,Christopher L. Morton,Kyoung Jin P. Yoon,Michal Harel,Boris Brumshtein,Israel Silman,Joel L. Sussman,Randy M. Wadkins,Philip M. Potter	34
16	The 3D structure of the anticancer prodrug CPT-11 with Torpedo californica acetylcholinesterase rationalizes its inhibitory action on AChE and its hydrolysis by butyrylcholinesterase and carboxylesterase 2005 ·Chemico-Biological Interactions ·Michal Harel,Janice L. Hyatt,Boris Brumshtein,Christopher L. Morton,Randy M. Wadkins,Israel Silman,Joel L. Sussman,Philip M. Potter	13
17	Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymesbreakdown → 2004 ·Nature Structural & Molecular Biology ·Michal Harel,Amir Aharoni,Leonid Gaidukov,Boris Brumshtein,Olga Khersonsky,Ran Meged,Hay Dvir,Raimond B. G. Ravelli,Andrew A. McCarthy,Lilly Toker,Israel Silman,Joel L. Sussman,Dan S. Tawfik	501
18	Preliminary X-ray crystallographic analysis of a soluble form of MntC, a periplasmic manganese-binding component of an ABC-type Mn transporter fromSynechocystis sp. PCC 6803 2002 ·Acta Crystallographica Section D Biological Crystallography ·Noam Adir,(unknown),Boris Brumshtein,(unknown)	5

About Boris Brumshtein

Boris Brumshtein is a scholar working on Clinical Biochemistry, Biochemistry and Organic Chemistry, having authored 18 papers that have together received 1.3k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (7 papers), Carbohydrate Chemistry and Synthesis (6 papers) and Lysosomal Storage Disorders Research (5 papers). The work is most often cited by research in Clinical Biochemistry (387 citations), Biochemistry (161 citations) and Pharmacology (321 citations). Boris Brumshtein has collaborated with scholars based in Israel, United States and France. Frequent co-authors include Joel L. Sussman, Israel Silman, Michal Harel, Lilly Toker, Anthony H. Futerman, Hay Dvir, Andrew A. McCarthy, Ran Meged, Raimond B. G. Ravelli and Leonid Gaidukov. Their work appears in journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Nature Structural & Molecular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact